• Font Size:
  • Print

On November 8th I posted a comment concerning Jim Cramer’s call on Nitromed (ticker: NTMD). Almost two months later the stock has failed to retain the “Cramer Spike.

BioBlogger

About this author:
Become a Contributor Submit an Article

ETFs In Focus